Single-Use Bioprocessing Market to Hit USD 34.9 Billion by 2029, Surging at 14.5% CAGR | MarketsandMarkets™
Articolo Precedente
Articolo Successivo
Browse in-depth TOC on "Single-Use Bioprocessing Market"
739 - Tables
61 - Figures
595 - Pages
Global Single-Use Bioprocessing Market Dynamics
Driving Force: Improved Productivity and Contamination Risk Reduction
Single-use bioprocessing systems optimize operations by replacing extensive cleaning procedures with disposable components. This accelerates product substitutions and transitions, boosting equipment utilization and overall production throughput. By minimizing downtime and enhancing efficiency, these technologies meet escalating biologics demand, accelerating new therapy launches, and market expansion. Their closed, disposable design minimizes microbial and cross-contamination risks between batches, ensuring product purity and consistency, complying with regulatory standards, and enhancing consumer confidence in biologic drug safety and efficacy.
Challenges: Leachable and Extractive Hurdles
Leachables and extractables, migrating from single-use materials into biopharmaceutical products, pose risks to quality, safety, and compliance. Their interaction with drug substances or formulations can degrade products, alter efficacy, or induce toxicity. Identifying, characterizing, and mitigating these substances demands extensive analytical testing and risk assessment, adding complexity and cost to development and manufacturing processes.
Opportunity: Emerging Market Potential
While mature markets embrace single-use technologies, emerging economies like China, India, Brazil, and Mexico offer significant growth opportunities. Increased healthcare needs, biopharmaceutical infrastructure investments, and supportive policies create fertile ground for expansion, making these regions key targets for single-use bioprocessing market players.
Challenge: Standardization Deficiency
The lack of standardization across single-use designs hampers adoption and efficiency. Variability in components and designs complicates integration, compliance, and supply chain management. Inconsistent quality and performance across manufacturers impact reproducibility and product quality, hindering widespread implementation.
Global Single-Use Bioprocessing Industry Ecosystem Analysis
The ecosystem comprises raw material suppliers, product manufacturers, and end users like pharmaceutical and biotechnology firms, CMOs & CROs, and academic institutions. Manufacturers offer bioreactors, filtration systems, chromatography equipment, and consumables, forming a critical part of the bioprocessing landscape.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=231651297
Single-Use Bioprocessing Market Segment Insights
Dominance of Single-Use Bags & Containers in 2023
In 2023, the single-use bags and containers segment emerged as the frontrunner in the single-use bioprocessing industry. These components offer a disposable alternative to traditional glass and rigid plastic carboys in various bioprocess applications. They enhance process reliability by minimizing the risk of cross-contamination between batches and products. Additionally, they eliminate the need for time-consuming clean-in-place (CIP) and sterilization-in-place (SIP) operations, optimizing capacity utilization. The expanded application of single-use bags across biomanufacturing processes is a key driver for the market's growth in this segment.
Upstream Bioprocessing Segment Takes the Lead
The upstream bioprocessing segment claimed the largest share of the single-use bioprocessing market in 2023. This dominance is attributed to the widespread adoption of single-use bioprocessing in biopharmaceutical formulation, particularly supporting upstream bioprocessing. Furthermore, the growing demand for biologics such as cell and gene therapy and monoclonal antibodies (mAbs) further fuels the growth of this segment.
Regional Insights: North America Leads the Way
North America emerged as the largest regional market for the single-use bioprocessing industry in 2023, followed closely by Europe and the Asia Pacific. This leadership position is supported by several factors, including the presence of key biopharmaceutical research and development facilities in the region and the rising demand for essential biopharmaceutical products like monoclonal antibodies, vaccines, gene therapies, and cell therapies. These factors collectively contribute to North America's significant share in the single-use bioprocessing market.
Recent Innovations in Single-Use Bioprocessing Industry
Cytiva's Xcellerex Magnetic Mixer:
Cytiva unveiled the Xcellerex magnetic mixer in April 2024, a breakthrough single-use mixing system available in capacities of 2,000 and 3,000 liters. Specifically designed for large-scale manufacturing processes of monoclonal antibodies (mAb), vaccines, and genomic medicines, this system promises enhanced efficiency and scalability for biopharmaceutical production.
Merck KGaA's Ultimus Single-Use Process Container Film:
In April 2023, Merck KGaA introduced the Ultimus single-use process container film, a cutting-edge solution designed to offer unparalleled durability and leak resistance. Tailored for single-use assemblies utilized in bioprocessing liquid applications, this innovative film sets new standards for reliability and performance, ensuring seamless operations and product integrity in biopharmaceutical manufacturing.
For more information, inquire now! Inquire Now
Related Reports:
Pharmaceutical Filtration Market
Get access to the latest updates on Single Use Bioprocessing Companies and Single Use Bioprocessing Market Share
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/
View original content:https://www.prnewswire.co.uk/news-releases/single-use-bioprocessing-market-to-hit-usd-34-9-billion-by-2029--surging-at-14-5-cagr--marketsandmarkets-302172874.html
